NOVN.CH

92.94

-2.73%↓

NOVN.CH

92.94

-2.73%↓

NOVN.CH

92.94

-2.73%↓

NOVN.CH

92.94

-2.73%↓

NOVN.CH

92.94

-2.73%↓

Search

Roche Holding AG

Отворен

СекторЗдравеопазване

262.4 -2.81

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

261.2

Максимум

268.6

Ключови измерители

By Trading Economics

Приходи

5.8B

7.8B

Продажби

297M

31B

P/E

Средно за сектора

23.333

34.393

Дивидентна доходност

3.62

Марж на печалбата

25.31

Служители

103,249

EBITDA

6B

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

3.62%

2.54%

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-589M

205B

Предишно отваряне

265.21

Предишно затваряне

262.4

Настроения в новините

By Acuity

61%

39%

325 / 374 Класиране в Healthcare

Roche Holding AG Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

24.07.2025 г., 15:09 ч. UTC

Печалби

Roche Weighs Selling Drugs Directly to Patients in Bid to Lower U.S. Prices -- Update

24.07.2025 г., 05:36 ч. UTC

Печалби

Roche Backs 2025 Views After Strong Sales of Key Drugs

11.06.2025 г., 08:25 ч. UTC

Придобивния, сливания и поглъщания

EQT, Sanofi Co-Led $135 Million Funding Round for Spanish Biotech Company SpliceBio

12.05.2025 г., 02:16 ч. UTC

Значими двигатели на пазара

Asia Pharma Stocks Fall After Trump's Plan to Cut Drug Costs

24.04.2025 г., 07:30 ч. UTC

Печалби

Roche Sales Gain on Boost From Key Drugs Amid U.S. Production Push -- Update

24.04.2025 г., 05:31 ч. UTC

Печалби

Roche Sales Rise Boosted By Key Drugs

9.04.2025 г., 09:39 ч. UTC

Значими двигатели на пазара

Pharma Stocks Tumble After Trump Threatens Tariffs on Medicines

5.08.2025 г., 10:40 ч. UTC

Пазарно говорене

Roche, Novartis Face Limited Tariff Headwinds for Now -- Market Talk

24.07.2025 г., 06:52 ч. UTC

Пазарно говорене
Печалби

Roche Looks Confident in a Tricky Environment -- Market Talk

24.07.2025 г., 05:05 ч. UTC

Печалби

Roche Backs 2025 View

24.07.2025 г., 05:05 ч. UTC

Печалби

Correct: Roche 1H Diagnostics Sales Down 3%, Reported

24.07.2025 г., 05:04 ч. UTC

Печалби

Correct: Roche 1H Sales Rose 4% On Year , Reported

24.07.2025 г., 05:04 ч. UTC

Печалби

Roche 1H Net Pft Was Seen at CHF8.4B

24.07.2025 г., 05:04 ч. UTC

Печалби

Roche 1H Net Pft CHF7.8B

24.07.2025 г., 05:03 ч. UTC

Печалби

Roche 1H Oper Pft CHF12.0B

24.07.2025 г., 05:03 ч. UTC

Печалби

Roche 1H Diagnostics Sales Down 3% at Constant Currency

24.07.2025 г., 05:03 ч. UTC

Печалби

Roche 1H Sales Rose 4% On Year at Constant Currency

24.07.2025 г., 05:02 ч. UTC

Печалби

Roche 1H Sales CHF30.9B , In Line With Analyst Views

21.07.2025 г., 06:44 ч. UTC

Пазарно говорене

Roche Drug Candidate Disappoints in Lung Disease Trials -- Market Talk

16.06.2025 г., 08:55 ч. UTC

Горещи акции

Stocks to Watch: Victoria's Secret, Renault, U.S. Steel, Sarepta -- WSJ

3.06.2025 г., 07:51 ч. UTC

Пазарно говорене

Roche Unlikely to Get Revenue Boost From Tecentriq Combination With Lurbinectedin -- Market Talk

21.05.2025 г., 07:20 ч. UTC

Пазарно говорене

Roche Lymphoma Drug Columvi Dealt Setback by FDA Committee -- Market Talk

2.05.2025 г., 06:25 ч. UTC

Пазарно говорене
Печалби

Roche Shows Pipeline Progress But Near-Term Risks Remain -- Market Talk

24.04.2025 г., 09:39 ч. UTC

Пазарно говорене
Печалби

Roche's Pipeline in Focus After Solid Results -- Market Talk

24.04.2025 г., 09:24 ч. UTC

Пазарно говорене
Печалби

Roche's Reiterated Outlook Looks Reassuring -- Market Talk

24.04.2025 г., 09:18 ч. UTC

Пазарно говорене
Печалби

Roche's Results Are Solid -- Market Talk

24.04.2025 г., 05:16 ч. UTC

Топ новини

Roche Sales Rise, Boosted By Key Drugs

22.04.2025 г., 10:51 ч. UTC

Топ новини

Drug Companies Step Up 'Make in America' Plans to Counter Tariffs -- WSJ

15.04.2025 г., 09:55 ч. UTC

Пазарно говорене

U.S Pharma Import Probe Clouds Clarity for EU Companies -- Market Talk

9.04.2025 г., 10:03 ч. UTC

Пазарно говорене
Печалби

Roche's Eye Drug in Focus for 1Q Earnings -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Roche Holding AG Прогноза

Настроение

By Acuity

325 / 374 Класиране в Здравеопазване

Настроения в новините

Мечи доказателства

Волатилност

Под средното

Обем новини (RCV)

Над средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. It has strategic discovery collaboration with Flare Therapeutics Inc. proteomic and mass spectrometry platform and expertise to discover novel small molecules aimed at transcription factor targets in oncology. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.